In the press

James Carthew comments on latest Saba actions in Investment Week

Biotech trusts top performance charts in February

James Carthew comments on the latest Saba actions in Linus Uhlig’s article:

“Insanity is doing the same thing over and over again and expecting different results. I keep saying that I cannot follow the logic to Saba’s actions but maybe there just is not any.”

Read the article here